Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. [Review] (Record no. 10924)

000 -LEADER
fixed length control field 03971nam a22006737a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210607s20212021 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0002-8703
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ahj.2021.02.009 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S0002-8703(21)00048-X [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number 33609498
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Waksman, Ron
190 ## -
-- Asami M
190 ## -
-- Iglesias JF
190 ## -
-- Kandzari DE
190 ## -
-- Koolen J
190 ## -
-- Lefevre T
190 ## -
-- Muller O
190 ## -
-- Piccolo R
190 ## -
-- Pilgrim T
190 ## -
-- Rothenbuhler M
190 ## -
-- Saito S
190 ## -
-- Siontis GC
190 ## -
-- Slagboom T
190 ## -
-- Waksman R
190 ## -
-- Windecker S
245 ## - TITLE STATEMENT
Title Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. [Review]
251 ## -
-- American Heart Journal. 235:140-148, 2021 05.
251 ## -
-- American Heart Journal. 235:140-148, 2021 May.
252 ## -
-- Am Heart J. 235:140-148, 2021 05.
252 ## -
-- Am Heart J. 235:140-148, 2021 May.
253 ## -
-- American heart journal
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2021
260 ## - PUBLICATION, DISTRIBUTION, ETC.
-- ppublish
260 ## - PUBLICATION, DISTRIBUTION, ETC.
-- 2021
269 ## -
-- FY2021
520 ## - SUMMARY, ETC.
Summary, etc. BACKGROUND: Newest generation drug-eluting stents combine biodegradable polymers with ultrathin stent platforms in order to minimize vessel injury and inflammatory response. Evidence from randomized controlled trials suggested that differences in stent design translate into differences in clinical outcome. The aim of the present study was to evaluate the safety and efficacy of ultrathin strut, biodegradable polymer sirolimus eluting stents (BP SES) compared with thin strut, durable polymer everolimus-eluting stents (DP EES) among patients undergoing percutaneous coronary intervention (PCI).
520 ## - SUMMARY, ETC.
Summary, etc. CONCLUSIONS: In this patient-level meta-analysis of 5 randomized controlled trials, BP SES were associated with a similar risk of target-lesion failure compared with DP EES among patients undergoing PCI.
520 ## - SUMMARY, ETC.
Summary, etc. METHODS: We pooled individual participant data from 5 randomized trials (NCT01356888, NCT01939249, NCT02389946, NCT01443104, NCT02579031) including a total of 5,780 patients, and performed a one-stage meta-analysis using a mixed effects Cox regression model.
520 ## - SUMMARY, ETC.
Summary, etc. RESULTS: At a median duration of follow-up of 739 days (interquartile range 365-1,806 days), target-lesion failure occurred in 337 (10.3%) and 304 (12.2%) patients treated with BP SES and DP EES (HR 0.86, 95%CI 0.71-1.06, P = .16). There were no significant differences between BP SES and DP EES with regards to cardiac death (111 (3.4%) vs 102 (4.1%); HR 1.05, 95%CI 0.80-1.37, P=.73), target-vessel myocardial infarction (136 (4.1%) vs 126 (5.0%), HR 0.79, 95%CI 0.62-1.01, P=.061), and clinically-driven target-lesion revascularization (163 (5.0%) vs 147 (5.9%); HR 0.94, 95%CI 0.75-1.18, P=.61). The effect was consistent across major subgroups. In a landmark analysis, there was no significant interaction between treatment effect and timing of events.
520 ## - SUMMARY, ETC.
Summary, etc. STUDY REGISTRATION: PROSPERO registry (CRD42018109098). Copyright (c) 2021 Elsevier Inc. All rights reserved.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Absorbable Implants
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Coronary Artery Disease/su [Surgery]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Everolimus/pd [Pharmacology]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Percutaneous Coronary Intervention/mt [Methods]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Polymers
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Sirolimus/pd [Pharmacology]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug-Eluting Stents
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prosthesis Design
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Function Journal Article
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://dx.doi.org/10.1016/j.ahj.2021.02.009
857 ## -
-- https://dx.doi.org/10.1016/j.ahj.2021.02.009
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 2021-03-10 33609498 2021-03-10 2021-03-10 Journal Article

Powered by Koha